We now officially have a #pediatric version of the #LVAD decision aid pamphlet! After a lot of work and collaboration with Stanford Children's VAD program and ACTION , we are very excited to have a final product for programs to use for free! Visit: patientdecisionaid.org/lvad/

This is really important when thinking about VAD implant. Plan for > 108 days for small kid on Berlin. Blood type O. Will require lots of bival to keep these kids safe. ⁦ACTION⁩ should do journal club in this info. onlinelibrary.wiley.com/doi/10.1111/aj…

An amazing physician, mentor and leader. Thanks for all that you do Angie Lorts!

“We hope this story can be the beginning of hope and not the end,” Mr. Bennett said. #MedTwitter #MedEd #transplant United Network for Organ Sharing (UNOS) The ISHLT PHTSociety ACTION Transplant Families nytimes.com/2022/03/09/hea…

Does Liver Disease Progress in survivors of HTx for a Failing Fontan? Toronto ACHD Program Rafa Alonso Aliya Gulamhusein Filio Billia Ajmera Transplant Centre UHN present 10 adult HTX recipients where there was resolution of ascites, non-progression of FALD and freedom from HCC bit.ly/3KJZuki

Must-see session on 4/29 at 1:30p ET as Dr. Sharon Chen of Stanford Children's presents "Outcomes After Initial Heart Failure Consultation In Fontan Patients” at #ISHLT2022. The ISHLT #PedsHF #Collaboration #CardioTwitter

.Sowmya Bala C.S. Mott Children's at #ACC22- national survey data on representation women and URRM in the field across 85% of US academic peds cardiology programs, much work to be done

#OnlineFirst Trivedi J et al Trends in Contemporary Use of Ventricular Assist Devices in Children Awaiting Heart Transplantation and Their Outcomes by Race/Ethnicity ow.ly/rJ2h50INHa7 @jaimtriv UofL Med School The University of Mississippi Medical Center #RacialDisparities #PedsVAD #PedsCards #PedsHTx

Representation matters! This little beauty has a doll with a VAD just like her, thanks to some magic 3D printing from her dad. University of Utah PICU #playtherapy #PedsCICU (Permission to share given by parent)

Is early cardiac allograft vasculopathy (CAV) more aggressive than later CAV in Peds HT? Later onset CAV was associated with improved 5-year graft survival, but similar and poor long-term outcomes. Michael Khoury Jennifer Conway PHTSociety bit.ly/3Fx6waV

This is important and needs the attention of our field. #pedhearttxp #healthequity

Total Cardiac Volume Ratio can predict short-term size-match related complications in pediatric heart transplantation 🫀 Nick Szugye MD 🔗: jhltonline.org/article/S1053-…

📢 Children's book about a patient with a #VAD Just published by Stanford University Stanford Health Care LVAD coordinator Tabitha Belhomme & inspired by one of her former patients! What a fantastic accomplishment💪 The ISHLT The Society of Thoracic Surgeons TCC Community of Practice (TCC COP) - AST amazon.com/LVAD-Man-Tabit…

Very proud of the team and this work with ACTION. High hopes that this will be a positive initial step toward improving outcomes for people #Fontan circulatory failure by getting them to the appropriate care at the appropriate time. Adam Lubert ahajournals.org/doi/abs/10.116…

Can VADs be used in muscular dystrophy patients? ACTION’s newest work implies so, although more work on defining suitable patients and measuring quality of life are needed next steps. #PedsHF Deipanjan Nandi, MD 🔗: jhltonline.org/article/S1053-…

Childhood heart surgery can leave invisible scars. A Wall Street Journal editor found that the aftermath of her own procedures was more complex than she knew. on.wsj.com/3oSLxes

PREHAB ALERT! Rabia Khan Sam Wittekind Farhan Zafar David L. S. Morales @DavePengMD Christopher Almond Danielle Burstein et al. demonstrate functional status prior to pediatric heart transplant is a potentially modifiable risk factor for important outcomes. 🔗: jhltonline.org/article/S1053-…

This link provides 50 days of free access to our article showing why children should not have lost access to the HVAD ventricular assist device #LVAD ACTION PHTSociety Jennifer Conway Shahnawaz Amdani authors.elsevier.com/c/1hk9D3lUpLZv…

Apixaban is a safe and well-tolerated alternative to vitamin K antagonists or low-molecular-weight heparin for thromboprophylaxis in pediatric heart disease. bit.ly/41aoYRu #JACC #cvPed #Apixaban #CardioTwitter #Cardiology #pediatrics

VAD use for failed stage II palliation (S2P) is increasing with limited data on outcomes. ACTION authors leveraged the registry to analyze data on the clinical course, complications, and survival of systemic VADs (SVAD) after S2P: bit.ly/3VfbhzW.